Hospital
Bertrand Chaffee Hospital
Bertrand Chaffee Hospital was paid $3.09M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoBERTRAND CHAFFEE HOSPITAL
SPRINGVILLE, NY 14141
SPRINGVILLE, NY 14141
33aNPI1275553521assigned 07/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.09M
24GClaims127,161
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#100 of 231
Median peer was paid$561K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,236 | $74K | |
| 2019 | 6,681 | $181K | |
| 2020 | 18,926 | $421K | |
| 2021 | 27,337 | $638K | |
| 2022 | 24,994 | $655K | |
| 2023 | 27,201 | $648K | |
| 2024incomplete | 19,786 | $469K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 4,287 | 4,195 | $550K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 4,482 | 4,253 | $453K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.3% | 2,079 | 1,953 | $288K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 5,913 | 5,560 | $285K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.5% | 7,210 | 6,490 | $232K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.7% | 1,005 | 992 | $116K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.5% | 1,872 | 1,785 | $107K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.2% | 745 | 735 | $98K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.9% | 1,363 | 326 | $89K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 1,098 | 1,075 | $89K |
| 80053 | Comprehensive metabolic panel | 2.5% | 9,717 | 8,399 | $77K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 1,121 | 1,033 | $76K |
108 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.3% | 2,264 | $70K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 824 | $65K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 1,072 | $60K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 2,464 | $49K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 1,958 | $38K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 1,147 | $36K |
| 83880 | <1% | 2,047 | $22K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,571 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 343 | $20K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,430 | $17K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 206 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 532 | $15K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,276 | $14K |
| 80305 | <1% | 1,883 | $13K | |
| 80061 | Lipid panel | <1% | 2,042 | $12K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 98 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 187 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,374 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,682 | $11K |
| 84439 | <1% | 1,180 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,040 | $8K |
| 93976 | <1% | 324 | $8K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 88 | $7K |
| 0011A | <1% | 171 | $5K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 39 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,294 | $4K |
| 99441 | <1% | 203 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,036 | $4K |
| 82607 | <1% | 301 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,298 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 69 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 343 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 87 | $3K |
| 90686 | <1% | 161 | $3K | |
| 87634 | <1% | 659 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 82 | $2K |
| 85610 | <1% | 4,320 | $2K | |
| 85730 | <1% | 3,314 | $2K | |
| 81001 | <1% | 1,590 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 21 | $2K |
| 81003 | <1% | 2,754 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 47 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 303 | $2K |
| 85027 | <1% | 1,031 | $2K | |
| 0012A | <1% | 79 | $2K | |
| 83735 | <1% | 2,945 | $2K | |
| 84153 | <1% | 93 | $2K | |
| 20610 | <1% | 47 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 177 | $1K |
| 97162 | <1% | 13 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 125 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $901.54 |
| 83690 | <1% | 1,899 | $806.82 | |
| 71045 | Radiologic examination, chest; single view | <1% | 542 | $691.53 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 119 | $623.20 |
| 81025 | <1% | 401 | $617.84 | |
| 82150 | <1% | 1,848 | $600.61 | |
| 86769 | <1% | 30 | $592.32 | |
| 73564 | <1% | 29 | $581.13 | |
| 84484 | <1% | 1,809 | $483.18 | |
| 84703 | <1% | 1,175 | $480.99 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 182 | $417.02 |
| 73630 | <1% | 34 | $378.68 | |
| 83605 | <1% | 2,167 | $377.50 | |
| 85379 | <1% | 200 | $373.22 | |
| 82550 | <1% | 1,744 | $346.57 | |
| 73610 | <1% | 26 | $298.70 | |
| 82746 | <1% | 25 | $278.52 | |
| 73030 | <1% | 13 | $276.32 | |
| 72110 | <1% | 15 | $276.00 | |
| 99401 | <1% | 12 | $266.89 | |
| 73130 | <1% | 29 | $190.55 | |
| 83540 | <1% | 43 | $189.68 | |
| 85651 | <1% | 133 | $187.19 | |
| 3074F | <1% | 105 | $140.00 | |
| 86803 | <1% | 12 | $114.92 | |
| 82570 | <1% | 30 | $110.66 | |
| 82043 | <1% | 28 | $100.60 | |
| 83550 | <1% | 27 | $92.14 | |
| 93041 | <1% | 1,209 | $78.11 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,479 | $68.72 |
| 73110 | <1% | 17 | $67.06 | |
| 85007 | <1% | 210 | $55.61 | |
| 87088 | <1% | 25 | $46.86 | |
| 3078F | <1% | 64 | $40.00 | |
| 87186 | <1% | 25 | $34.72 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 12 | $33.36 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 35 | $29.00 |
| 99152 | <1% | 14 | $25.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,612 | $15.88 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 37 | $13.00 |
| 94761 | <1% | 2,026 | $11.86 | |
| J2704 | Injection, propofol, 10 mg | <1% | 110 | $7.80 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 277 | $5.48 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 90 | $2.61 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 32 | $0.50 |
| 99080 | 0% | 1,373 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 64 | $0.00 |
| 3725F | 0% | 14 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 39 | $0.00 |
| 87430 | 0% | 27 | $0.00 | |
| 3008F | 0% | 12 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 17 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 18 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 28 | $0.00 |
| 96376 | 0% | 13 | $0.00 | |
| 87040 | 0% | 39 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEBDON, KATHLEEN (NURSE ADMINISTRATOR)